
Medvolt is an AI-driven pharmaceutical R&D startup specializing in early-stage drug discovery and development. Their proprietary MedGraphR platform integrates generative AI, advanced physics-based simulations, and interpretable, data-centric AI models to accelerate drug discovery workflows, reduce costs, and improve success rates. The platform offers modular, scalable, and affordable solutions for small and large molecule drug discovery, drug repurposing, peptide therapeutics, and knowledge discovery through a comprehensive knowledge graph and AI-powered data curation. Medvolt collaborates globally with pharma and biotech companies, leveraging high-throughput proprietary datasets and expert validation to deliver actionable insights and novel therapeutic candidates, positioning itself as a leader in AI-augmented drug discovery innovation.

Medvolt is an AI-driven pharmaceutical R&D startup specializing in early-stage drug discovery and development. Their proprietary MedGraphR platform integrates generative AI, advanced physics-based simulations, and interpretable, data-centric AI models to accelerate drug discovery workflows, reduce costs, and improve success rates. The platform offers modular, scalable, and affordable solutions for small and large molecule drug discovery, drug repurposing, peptide therapeutics, and knowledge discovery through a comprehensive knowledge graph and AI-powered data curation. Medvolt collaborates globally with pharma and biotech companies, leveraging high-throughput proprietary datasets and expert validation to deliver actionable insights and novel therapeutic candidates, positioning itself as a leader in AI-augmented drug discovery innovation.